HCN Healthcare Recruiting

A new vaccine may lower high blood pressure.

A team of researchers from Cytos Biotechnology in Schlieren, Switzerland have developed a new vaccine named CYT006-AngQb for lowering blood pressure. The vaccine is to strengthen blood vessels that regulate blood pressure.

The vaccine was shown to be successful in a trial of 72 patients with mid and moderate hypertension. The patients were given to one or two doses of vaccine and a placebo after 4 and 12 weeks. The patients were been measured for blood pressure before the study and 14 weeks after it. They showed those having higher doses of vaccine have systolic blood pressure by 9 millimetres of mercury, diastolic pressure by 4 millimetres of mercury.

Diastolic is the blood pressure in arteries while heart is resting. It’s the bottom number of pressure measuring. Systolic is the blood pressure in arteries while heart is beating. It’s the top number of pressure measuring.

Results were even better in morning times: at 8 am systolic pressure was reduced by 25mm, diastolic pressure was reduced by 13mm.

Researchers suggest that this new vaccine a few times a year will replace blood pressure pills and lower hypertension.